Skip to content

Month: June 2021

Exploring the Stakeholders Involved with Enabling Autologous Cell Therapies (Part 3)

How well have you mapped the stakeholders and functions involved with enabling the successful order, delivery, and infusion of your ACT product? Unlike traditional specialty products, even more sophisticated specialty
Read More

Exploring the Experience with Autologous Cell Therapies (Part 2)

What Experience are you Designing for your #Celltherapy? Nuvera’s second infographic in a series of five focuses on highlighting how the experiences of patients, referring physicians, treatment centers, and the
Read More

Introducing Nuvera’s Infographic Series on Autologous Cell Therapies (Part 1)

Commercializing a CAR-T or other #Celltherapy? Nuvera is excited to share a newly developed series touching upon several commercialization issues surrounding Autologous Cell Therapies (ACTs) based upon over six years
Read More